X4 Pharmaceuticals, Inc.

XFORNASDAQ Capital Market·USD·Closed

XFORNASDAQ·USD·Closed

$3.85

+3.77%

$3.85

+$0.14 (3.77%)

52W Range

72thpctl

Volume

1.09×avg

Mkt Cap

363.13MUSD

P/E

-5.2TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

72thpctl

Volume

1.09×avg

Market Cap

363.13MUSD

P/E Ratio

-5.2TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+1273.2% / yr

Operating margin-1084.4%

ROIC-39.5%

Financially safe

Stretched

Debt / equity0.46×

Interest coverage-11.1×

Current ratio10.18×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required